These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. Seen TK; Sayed M; Bilal M; Reyes JV; Bhandari P; Lourdusamy V; Al-Khazraji A; Syed U; Sattar Y; Bansal R World J Gastroenterol; 2021 Jun; 27(23):3238-3248. PubMed ID: 34163108 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet? Alkhouri N; Feldstein AE Metabolism; 2016 Aug; 65(8):1087-95. PubMed ID: 26972222 [TBL] [Abstract][Full Text] [Related]
9. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Long MT; Noureddin M; Lim JK Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345 [TBL] [Abstract][Full Text] [Related]
10. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease. Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026 [No Abstract] [Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Basu R; Noureddin M; Clark JM Mayo Clin Proc; 2022 Sep; 97(9):1700-1716. PubMed ID: 36058582 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Alqahtani SA; Chan WK; Yu ML Clin Liver Dis; 2023 May; 27(2):211-223. PubMed ID: 37024203 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697 [TBL] [Abstract][Full Text] [Related]
18. The Future of Nonalcoholic Fatty Liver Disease Treatment. Mazhar K Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676 [TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
20. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Crespo M; Lappe S; Feldstein AE; Alkhouri N Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]